Versatile live attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity
A. Yoshida, S. Okamura, S. Torii, S. Komatsu, P. Miyazato, S. Ueno, H. Suzuki, W. Kamitani, C. Ono, Y. Matsuura, S. Takekawa, K. Yamanishi, H. Ebina
This study develops a live attenuated SARS-CoV-2 vaccine platform using temperature-sensitive mutations that provides protection against homologous and heterologous viral challenges.
bioRxiv · Feb 15, 2021Microbiology